Indian Ovarian Cancer Institute (IOCI) · Ahmedabad & Gandhinagar
Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.
Last updated: 24-Oct-2026
Gene testing, treatment and risk-reducing surgery, for women with ovarian cancer and for healthy BRCA carriers · Gota OPD, Ahmedabad · Apollo Hospital, Bhat, Gandhinagar
IN SHORT
A BRCA change is a fault in a gene that normally repairs DNA. It can run in a family, and it raises the risk of ovarian and breast cancer.
Every woman with ovarian cancer should be offered a gene test, whatever her family history. The result can change the tablet she takes after chemotherapy.
A healthy woman who carries the change can lower her ovarian cancer risk with a planned operation. Timing depends on which gene it is and on her family.
One result opens a door for sisters, daughters and cousins. They can be tested before any illness appears.
Dr Swati Shah
MS, DrNB (Surgical Oncology)
Ovary Cancer Surgeon
Apollo Hospital, Bhat, Gandhinagar · Gota OPD, Gota, Ahmedabad · 18 years of experience
★★★★★ 4.96 from 24 Google reviews
Indian Ovarian Cancer Institute (IOCI). Dr Swati Shah holds MS, DrNB (Surgical Oncology). She studied medicine and trained in general surgery at Maulana Azad Medical College, Delhi, and trained in surgical oncology at Rajiv Gandhi Cancer Institute and Research Centre, Delhi. She has 18 years of experience in cancer surgery for women and has worked on the robotic console since 2013.
A gene result is never read alone. It goes to a tumour board with a medical oncologist, a radiologist and a pathologist, and to a genetic counsellor when the family is involved.
Any woman with ovarian, tubal or peritoneal cancer should be offered a test. Healthy women are tested when their family history points to an inherited change.
| Situation | What is advised |
|---|---|
| A woman with newly found ovarian, tubal or peritoneal cancer. | A blood test for inherited changes, and a test on the tumour. Both are sent early. |
| A woman whose ovarian cancer came back. | The same tests, if they were never done. The result still guides the next drug. |
| A healthy woman with a mother, sister or daughter who had ovarian cancer. | Counselling first, then a blood test, ideally with the affected relative’s result in hand. |
| A family with breast cancer at a young age, or in both breasts, or in a man. | Counselling and a gene panel, because the same genes drive breast and ovarian cancer. |
| A family with bowel or womb cancer at a young age. | A check for Lynch syndrome, which also raises ovarian cancer risk. |
| A woman whose relative already has a known BRCA change. | A single targeted test for that one change. It is quicker and cheaper than a full panel. |
Family history alone misses many carriers. Some families are small, some have mostly men, and in some the cancers were never named. That is why a woman who already has ovarian cancer is tested whether or not anyone else was ill.
The inherited test is a blood sample. The tumour test uses tissue from the biopsy or the operation. They answer different questions.
A negative blood test does not make a woman’s family safe if she herself never had cancer. It only clears the one change that was looked for. How each blood test and scan result alters the plan is set out on our page on what each test result decides.
The result does not change the operation. It changes what comes after chemotherapy, and it tells the family where to look.
| Finding | What it usually means for treatment |
|---|---|
| A harmful BRCA change in blood or tumour. | A tablet that blocks DNA repair in cancer cells (a PARP inhibitor) is advised after chemotherapy, if the cancer has responded. |
| No BRCA change, but the tumour shows HRD. | The same type of tablet may help, sometimes with another drug. The gain is discussed honestly. |
| Neither BRCA nor HRD found. | The benefit of the tablet is smaller. Other options, or watchful follow-up, are weighed. |
| A change of unknown meaning. | Treatment follows the tumour test and the scans. The family is not tested on this finding. |
| A cancer that returns years later. | Women with a BRCA change often respond well to platinum drugs again. That is useful to know in advance. |
The tablet is taken for a long time and some brands are costly. So the plan, the supply and the expense are talked through at the first visit. Waiting until the prescription counter is too late. The order of operation and chemotherapy is explained on our page on which treatment comes when.
The cancer operation is the same with or without a BRCA change. The aim is still to leave nothing visible behind.
A known change does not shrink or enlarge the operation. It does not make surgery safer to skip, and it does not make it urgent. What it does is settle the plan beyond the operation. The tablet after chemotherapy is lined up before discharge. Both ovaries and both tubes come out in the standard operation anyway, so there is no second operation to plan for them. Follow-up includes a conversation about the breasts, because the same gene raises breast cancer risk.
Whether the abdomen is opened or kept to keyhole depends on how far the disease has spread, not on the gene. That choice is described on our page on surgery first or chemotherapy first.
A woman who carries a BRCA change but has no cancer can be offered removal of both tubes and ovaries once her family is complete.
| Question | How it is decided |
|---|---|
| When? | For BRCA1 carriers, usually in the late thirties to early forties. For BRCA2, a few years later. Family history and childbearing wishes move this date. |
| What comes out? | Both fallopian tubes and both ovaries, whole, taken by keyhole or robot in most women. The womb stays unless there is another reason to take it. |
| What is checked? | Fluid is washed and sent. Every part of the tubes and ovaries is sliced and studied, because a hidden early cancer is found in some carriers. |
| What changes afterwards? | Periods end and menopause begins at once. Hot flushes, sleep, bones and heart are looked after from the first week. |
| Hormone treatment? | Often possible for a carrier who has not had breast cancer, up to the usual age of menopause. It is decided with the breast team. |
| Is there an alternative? | Removing only the tubes first, and the ovaries later, is under study. It is not yet a substitute, and it is offered only as part of a clear plan. |
The operation lowers the risk of ovarian, tubal and peritoneal cancer a great deal. It does not remove the breast risk. So yearly breast scans under a breast specialist continue, and that plan is made at the same visit. Where a family carries Lynch syndrome, removal of the womb at the same sitting is discussed as well.
One woman’s result can protect her relatives. A close relative has an even chance of carrying the same change.
BRCA1 and BRCA2 are the well-known genes, but not the only ones. A wider panel looks at several others.
Changes in genes such as RAD51C, RAD51D, BRIP1 and PALB2 also raise ovarian or breast cancer risk. The Lynch syndrome genes raise the risk of womb, bowel and ovarian cancer. Each has its own age for risk-reducing surgery and its own follow-up. A panel test covers them in one sample, which is why it is chosen over testing gene by gene. More on the other situations that change the usual route is on our page on when the usual path does not fit.
These questions apply wherever you are being treated. The answers tell you whether the test will actually be used.
Testing carries little physical risk. Operations carry the usual risks, and a few certainties that you should hear before you decide.
| Risk or certainty | What it means |
|---|---|
| Worry after a result. Common. | Counselling before and after the test is planned for this. Time to absorb a result is built in. |
| A result of unknown meaning. | It is not acted on. It is reviewed again as knowledge grows. |
| Bleeding, infection, or injury to a nearby organ in keyhole surgery. | Uncommon. Explained in full before consent. |
| Early menopause. Certain after both ovaries are removed. | Symptoms, bones and heart health are treated, and hormone treatment is discussed. |
| Fertility ends. Certain after the ovaries are removed. | The operation is timed after childbearing. Egg freezing can be discussed before. |
| A small risk of cancer in the lining of the belly remains. | It is much lower than before surgery, but not zero. |
| Breast risk is not changed by this operation. Certain. | Breast checks continue with a breast specialist. |
Call the team the same day for fever with abdominal pain, heavy bleeding, a swollen painful leg, or sudden breathlessness after any operation.
Reviews below are shown as Google holds them. They describe one family’s experience, and no two women have the same disease or the same plan.
★★★★★
“I am very thankful to Dr. Swati Shah for treating and operating on my mother for ovarian cancer. From the first consultation to the surgery and follow-up, she was very supportive, caring, and explained everything clearly. We felt confident and comfortable under her care. The surgery went well, and my mother is recovering nicely. We are truly grateful for her expertise and dedication. Highly recommended for ovarian cancer treatment and surgery in Ahmedabad.”
— Sonal Soni, Google review
★★★★★
“We are extremely grateful to Dr. Swati Shah for treating my mother for ovarian cancer and performing her surgery. She is a very experienced, compassionate, and dedicated doctor. She explained the treatment and surgery very patiently and gave us confidence throughout the entire journey. The surgery went well, and my mother is doing much better now. Thank you, Dr. Swati Shah, for your excellent care and support. Highly recommended for ovarian cancer treatment.”
— Jay Udasi, Google review
★★★★★
“My relative received treatment for an ovarian condition at Indian Ovary Cancer Institution. The medical team provided clear explanations, professional care, and support throughout the treatment process. We truly appreciate their kindness and guidance. Thank you to the entire team for helping us through this journey.”
— Varsha Patel, Google review
These are Google reviews, shown exactly as written, from families treated for ovarian cancer at the IOCI clinic and at Apollo Hospital, Bhat.
The cost depends on the test chosen and the operation planned. You are given a written estimate before any admission.
A single-change test costs far less than a full panel, so the right test is chosen first. Apollo Hospital, Bhat works with the major insurers and with cashless cover, and its office handles the pre-authorisation. Cover for gene tests and for risk-reducing surgery differs between policies, so ask your insurer early. The tablet after chemotherapy is a separate cost, and often the largest one, which is why it is discussed at the first visit. Please bring every scan on a disc or a link, all gene and biopsy reports, your medicine list, your insurance card and an identity document.
Yes. It is advised whether or not anyone else in the family was ill. The result can choose the tablet taken after chemotherapy and tells relatives whether they should be tested.
No. A daughter has an even chance of carrying the change, and carrying it raises risk but does not mean illness. She can be tested as an adult, and a plan of checks and timed surgery lowers her risk.
Not the cancer operation. The aim is still to leave nothing visible behind. The result changes what follows chemotherapy and what is advised for the family.
Meet a cancer surgeon and a genetic counsellor. The usual advice is yearly breast checks. Once your family is complete, both tubes and ovaries are removed, at a time that depends on the gene.
Both are used. Blood shows an inherited change that matters to the family. The tumour test shows changes inside the cancer and guides the tablet after chemotherapy.
Consultation is at the Gota OPD, Ahmedabad. Operations are at Apollo Hospital, Bhat, Gandhinagar.
Indian Ovarian Cancer Institute (IOCI), Shah’s Gastro, Cancer & Robotic Surgery Centre
Dr Swati Shah — MS, DrNB (Surgical Oncology) · Ovary Cancer Surgeon
Consultation: Gota OPD, Gota, Ahmedabad. Surgery: Apollo Hospital, Bhat, Gandhinagar.
Gota OPD, Gota, Ahmedabad — SF-203, 2nd Floor, Olive Greens, S G Highway, Ahmedabad, Gujarat 382481. Directions
Apollo Hospital, Bhat, Gandhinagar — Plot No. 1 A, GIDC Bhat Industrial Estate, Bhat, Gandhinagar, Gujarat 382428. Directions
Call: +91-63590-11009 · WhatsApp: +91-63590-11009
Got a gene report, or a family where ovarian or breast cancer keeps appearing? Send the report, or write down who in the family had which cancer and at what age. Dr Swati Shah reads it before you arrive. The visit then goes on decisions, not on copying out a family tree. Call +91-63590-11009 · Bring the report to the visit
Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.
Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.
Department
Shah’s Gastro, Cancer & Robotic Surgery Centre
SF-203, 2nd Floor
Olive Greens, Gota
S G Highway, Ahmedabad
Gujarat, India 382481
Google map link:
https://maps.app.goo.gl/2wawX5nnDgjkKoeZA?g_st=iw
Apollo Hospital I.L
Plot No. 1 A,
Apollo Hospital International Limited,
GIDC Bhat, Industrial Estate,
Gandhinagar, Gujarat 382428
Google map link:
https://maps.app.goo.gl/jRYUHgH6rFdGsk5g8